Spiros Liras
Fondateur chez Initial Therapeutics Inc
Provenance du réseau au premier degré de Spiros Liras
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
203
| Public Company | Pharmaceuticals: Major | 203 |
Iowa State University
94
| College/University | Other Consumer Services | 94 |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge.
28
| Private Company | Investment Managers | 28 |
Nereid Therapeutics, Inc.
 Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA.
8
| Holding Company | Biotechnology | 8 |
Apertor Pharmaceuticals, Inc.
 Apertor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Alameda, CA.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Initial Therapeutics Inc
 Initial Therapeutics Inc BiotechnologyHealth Technology Opal Biosciences, Inc. operates as a biotechnology company. The company is headquartered in New York, NY.
5
| Holding Company | Biotechnology | 5 |
Evercrisp Biosciences, Inc.
 Evercrisp Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Evercrisp Biosciences, Inc. is a biotechnology company that focuses on the discovery and development of protein-based genome editors as therapeutics for multiple disease areas. The company is based in New York, NY.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Spiros Liras via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Princeton University | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Undergraduate Degree Graduate Degree | |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
Aulos Bioscience, Inc.
 Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Masters Business Admin Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Nine Square Therapeutics, Inc.
 Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Nine Square Therapeutics, Inc. provides biotechnology services. The company was founded in 2020 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Founder Director/Board Member | |
| BRAEBURN INC. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Private Equity Investor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| CELGENE | Biotechnology | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Aethon Therapeutics, Inc.
 Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services The company, co-founded by venture capital firm Apple Tree Partners and New York University cancer researchers Shohei Koide, Ph.D., and Benjamin G. Neel, Ph.D., unites immunotherapy and targeted therapy to expand the power and promise of both approaches for people living with cancer. Aethon Therapeutics, Inc. is based in New York, NY. Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that creates neoantigens by design to transform cancer treatments into cures. The company's novel anti-drug-peptide conjugate/mhc antibodies are designed to be used in combination with targeted covalent inhibitors of ras, egfr, and other oncogenic driver mutations to mount immune attacks and selectively kill residual cancer cells, including drug-resistant "persister" cells. The company was founded by Benjamin G. Neel, Shohei Koide. The CEO is Rajesh Chopra. | Hospital/Nursing Management | Chairman Chief Executive Officer Director/Board Member | |
Intergalactic Therapeutics, Inc.
 Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Ascidian Therapeutics, Inc.
 Ascidian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascidian Therapeutics, Inc. operates as a biotechnology research and development company. The company is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Replicate Bioscience, Inc.
 Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Founder | |
Galvanize Therapeutics, Inc.
 Galvanize Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer | |
| New York Medical College | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| The Leonard N Stern School of Business | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
Vion Pharmaceuticals, Inc.
 Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| University of Michigan | College/University | Masters Business Admin Doctorate Degree | |
| WHIRLPOOL CORPORATION | Electronics/Appliances | Director/Board Member Corporate Officer/Principal | |
| THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Director/Board Member Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| The University of Chicago Booth School of Business | College/University | Founder Masters Business Admin | |
| SPEXIS AG | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| New York University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Oxford | College/University | Graduate Degree Doctorate Degree | |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Rensselaer Polytechnic Institute | College/University | Undergraduate Degree Masters Business Admin | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Western Ontario | College/University | Undergraduate Degree Masters Business Admin | |
Galaxy Medical, Inc.
 Galaxy Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Galaxy Medical, Inc. provides biotechnology services. The company is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Limelight Bio, Inc.
 Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman Chief Executive Officer | |
| ARVINAS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member Director/Board Member | |
Tusker Medical, Inc.
 Tusker Medical, Inc. Medical SpecialtiesHealth Technology Tusker Medical, Inc. engages in the development of medical devices for ear, nose, and throat treatments. It offers iontophoresis system and tube delivery system. The company is headquartered in Menlo Park, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
The World Economic Forum USA, Inc.
 The World Economic Forum USA, Inc. Miscellaneous Commercial ServicesCommercial Services The World Economic Forum USA, Inc. operates an organization for economic reforms. The non-profit company is based in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Gala Therapeutics, Inc.
 Gala Therapeutics, Inc. BiotechnologyHealth Technology Gala Therapeutics, Inc. engages in biotech and pharma products. The company was founded in October 2015 by Jonathan Reuben Waldstreicher and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Founder | |
Galavant Therapeutics, Inc.
 Galavant Therapeutics, Inc. BiotechnologyHealth Technology Galavant Therapeutics, Inc. operates a biotechnology firm. The company is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| The University of Chicago | College/University | Director/Board Member Masters Business Admin | |
Adendra Therapeutics Ltd.
 Adendra Therapeutics Ltd. BiotechnologyHealth Technology Adendra Therapeutics Ltd. is an emerging British biotechnology company that was founded in 2021 as a spin-out of the Francis Crick Institute. The company is based in London, UK. The company is focused on discovering and developing new small molecule and biologic medicines for the treatment of a wide range of cancers and autoimmune diseases, building on new insights into dendritic cell biology. The company was founded in 2021 by Caetano Reis E Sousa, Raj Mehta. Raj Mehta has been the CEO since 2021. | Biotechnology | Chairman Chief Executive Officer | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Photys Therapeutics, Inc.
 Photys Therapeutics, Inc. Medical SpecialtiesHealth Technology Photys Therapeutics, Inc. is a company based in Cambridge, MA that was founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women's Hospital and the Broad Institute of MIT and Harvard. The company is advancing phosphorylation inducing chimeric small molecules (PHICs), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to treat a range of diseases including cancer, immune, metabolic, and rare diseases. PHICs enhance the pairing of specific kinases with disease target proteins, inducing precise phosphorylation at native and/or non-native sites, modulating key functions including activation, stabilization, trafficking, localization, phospho-antigen presentation, inactivation, degradation, and interactions of proteins. The company's approach unlocks diverse classes of targets, developing a new class of medicines for precise control of protein function. The company was founded by Amit Choudhary, David Steinberg, Edward Holson, Lizzie Ngo. David Steinberg has been the CEO since incorporation. | Medical Specialties | Director/Board Member Consultant / Advisor |
Statistiques
Internationale
| Etats-Unis | 44 |
| Royaume-Uni | 5 |
| Suisse | 3 |
| Canada | 2 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 16 |
| Commercial Services | 6 |
| Finance | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 462 |
| Corporate Officer/Principal | 230 |
| Independent Dir/Board Member | 112 |
| Chairman | 85 |
| Undergraduate Degree | 82 |
Relations les plus connectées
| Insiders | |
|---|---|
| James Kilts | 48 |
| Seth Harrison | 43 |
| Argeris Karabelas | 42 |
| Barbara Dalton | 35 |
| Henry McKinnell | 35 |
| Liam Ratcliffe | 32 |
| Peter Corr | 28 |
| Meghan Fitzgerald | 28 |
| Briggs Morrison | 26 |
| Dennis Ausiello | 26 |
| Robert Hugin | 24 |
| Michael Kauffman | 24 |
| Frederick Telling | 23 |
| Viviane Monges | 22 |
| Robert Karr | 21 |
- Bourse
- Insiders
- Spiros Liras
- Connexions Sociétés
